ArticlemBio2018
Processing of
Open access · goldAbstract read
In one paragraph
Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.
0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
70 citing papers in PubMed, 97 citations in OpenAlex.
- Structure and function of a fungal AB toxin-like chimerolectin involved in anti-nematode defense.The EMBO journal · 2026Article
- Fungi and colorectal cancer: from dysregulation to clinical translation.Gut pathogens · 2026Review
- Article
- Glycolysis-dependent sulfur metabolism orchestrates morphological plasticity and virulence in fungi.eLife · 2026Article
- Article
- Candida albicans Cells Lacking AP-2 Have Defective Hyphae and Are Avirulent Despite Increased Host Uptake and Intracellular Proliferation in Macrophages.Molecular microbiology · 2026Article
- Dynamic expression of candidalysin facilitates oral colonization of Candida albicans in mice.Nature microbiology · 2025Article
- Insights into the evolution of Candidalysin and recent developments.Archives of microbiology · 2025Review
- Review
- Inhibition of candidalysin production by methoxy-apo-enterobactin from Streptomyces ambofaciens CJD34 as a novel antifungal strategy against Candida albicans.Journal of microbiology (Seoul, Korea) · 2025Article
- Essential role of hepcidin in host resistance to disseminated candidiasis.Cell reports · 2025Article
- Deletion ofmSphere · 2025Article
- Article
- Article
- Immunity to pathogenic mucosal C. albicans infections mediated by oral megakaryocytes activated by IL-17 and candidalysin.Mucosal immunology · 2024Article
- Secretion of the fungal toxin candidalysin is dependent on conserved precursor peptide sequences.Nature microbiology · 2024Article
- Global fungal-host interactome mapping identifies host targets of candidalysin.Nature communications · 2024Article
- Article
- Host cell responses toFrontiers in cellular and infection microbiology · 2024Article
- Heterologous expression of the insect SVWC peptide WHIS1 inhibitsFrontiers in microbiology · 2024Article
10 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 5 institutions in 3 countries.
Jonathan P Richardson *Mucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom jonathan.richardson@kcl.ac.uk Selene.Mogavero@hki-jena.de.
Selene Mogavero *Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute (HKI), Jena, Germany jonathan.richardson@kcl.ac.uk Selene.Mogavero@hki-jena.de.ORCID 0000-0003-0642-0068
David L MoyesCentre for Host-Microbiome Interactions, Mucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Mariana BlagojevicMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Thomas KrügerDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute (HKI), Jena, Germany.
Akash H VermaDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Bianca M ColemanDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jacinto De La Cruz DiazDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Daniela SchulzDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute (HKI), Jena, Germany.
Nicole O PondeMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Giulia CarranoMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Olaf KniemeyerDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute (HKI), Jena, Germany.
Duncan WilsonMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.
Oliver BaderInstitute for Medical Microbiology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0002-1534-440X
Simona I EnoiuMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Jemima HoMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Nessim KichikMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
Sarah L GaffenDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute (HKI), Jena, Germany.
Julian R NaglikMucosal and Salivary Biology Division, Dental Institute, King's College London, London, United Kingdom.
King's College London · GBLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEUniversity of Pittsburgh · USUniversitätsmedizin Göttingen · DEUniversity of Aberdeen · GB
Funding
Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6MIL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1MIL-23/STAT3-Driven Oral Immune Responses to Candida albicansR01DE023815 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2014 to 2018
$1.9MBiotechnology and Biological Sciences Research Council BB-J016411-1Biotechnology and Biological Sciences Research Council BB/J016411/1Biotechnology and Biological Sciences Research Council BB/N014677/1Department of HealthMedical Research Council MR/J008303/1Medical Research Council MR/M011372/1Medical Research Council MR/N006364/1NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R01 DE023815NIDCR NIH HHS R37 DE022550Wellcome Trust 097377/Z/11/ZWellcome Trust 102549/Z/13/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
Protein Processing, Post-TranslationalProteolysisAnimalsCandida albicansCandidiasis, OralCarboxypeptidasesDisease Models, AnimalFungal ProteinsMiceProprotein ConvertasesVirulenceCarboxypeptidasesECE1 protein, Candida albicansFungal ProteinsProprotein ConvertasesCandida albicanscandidalysinfungal infectionkexinmucosal immunity
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.